Vaccinia virus recombinants expressing the herpes simplex virus type 1 (HSV-1) genes encoding ICP0 or ICP4 were used to identify the precise target antigen(s) of murine anti-viral cytotoxic T lymphocytes (CTL) specific for the non-structural immediate early proteins. These studies revealed that HSV-l-specific CTL, restricted to class I major histocompatibility complex genes of the H-2 k haplotype but not the H-2 d or H-2 b haplotypes, would lyse autologous cells expressing ICP4. HSV-l-specific CTL derived from various mice strains failed to lyse target cells expressing ICP0. Calculation of the frequencies of H-2k-restricted virusspecific CTL demonstrated that approximately a third of the total HSV-l-specific response was directed against ICP4. Immunization of mice with either recombinant vaccinia virus or transfected L cells expressing ICP4 induced HSV-l-specific lymphoproliferation and delayed hypersensitivity but CTLs were not induced. More importantly, such immunized animals were unable to resist or control a subsequent challenge with virulent HSV-1.
Introduction
As recovery from infections by herpesviruses involves the participation of cytotoxic T lymphocytes (CTL) (Martin & Rouse, 1989) , an understanding of which viral antigens are recognized by the CTL system becomes important. In murine cytomegalovirus (CMV) infection, the principal protein recognized by BALB/c CTL is a non-structural immediate early regulatory protein (Koszinowski et al., 1987) . The CTL response to human CMV includes structural glycoproteins as well as immediate early gene products but responses to the latter appear to predominate (Borysiewicz et al., I988) . In the case of herpes simplex virus type 1 (HSV-1), the identity of target antigens is unresolved and controversial. For example, of the seven major glycoproteins, three have been the subject of both positive and negative findings (Glorioso et al., 1985; Blacklaws et al., 1987; Rosenthal et al., 1987; McLaughlin-Taylor et al., 1988; Martin et al., 1989) . The confusion appears partly attributable to the influence of the major histocompatibility complex (MHC) class I genotype, but the particular system used to express the viral genes may also affect the outcome (Coupar et al., 1986; D. C. Johnson, personal communication) . Although one or more glycoproteins may act as HSV-reactive CTL targets, they are not the only proteins involved. Thus it has been shown, using target cells permitted to express only immediate early gene products following HSV infection, that such cells can be killed by class I-restricted HSV-specific CTL (Martin et al., 1988) . Frequency estimates of such cells by limiting dilution analysis showed that CTL precursors specific for immediate early gene products accounted for up to one-third of the HSVspecific population. It remains unclear which of the five immediate early proteins contain epitopes recognized by CTL in the various mouse strains. In this report, we have assessed the role of two immediate early proteins, ICP0 and ICP4. Our results demonstrate a role for ICP4 in one of three mouse strains studied, but none of the strains appeared to recognize ICP0. Although ICP4 was recognized in vitro, a vaccinia virus vector expressing the gene failed to induce CTL responses in vivo and animals were not protected from HSV infections. Possible reasons for this failure and its relevance to HSV vaccines are briefly discussed.
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Methods
Viruses. HSV-1 strains KOS and McCrae were grown in Vero and Hep2 cells and their titre was determined on Vero cells. HSV-1 was u.v.-irradiated by exposing 2 x 108 TCIDso to a germicidal lamp (Sylvania Electric Products) at a distance of 3 cm for 2 rain. This resulted in a 105-fold reduction in virus titres.
The vaccinia virus recombinants containing the cloned genes for HSV-1 gD (VgD52, Cremer et al., 1985) , gB (VgBll; Cantin et al., 1987) , ICP4 (Vet4), ICP0 (Vet0) or the control thymidine kinase (TK)-negative vaccinia virus (VTK-) were grown in HeLa cells, purified on sucrose gradients and titrated as described previously (Cremer et al. 1985) .
The Vet4 and Vet0 recombinants were constructed as follows. The coding region for ICP4 was excised from a plasmid containing the XhoI C fragment from HSV-1 strain 17 as a 4489 bp Sal/DdeI fragment. The ends were filled and the fragment was cloned into the EcoRV site of plC-2OH as pTEG-2. A BgllI/ClaI fragment was excised from pTEG-2 and inserted between the BamHI and ClaI sites of the vaccinia virus recombination vector pATA-18 behind a mutated IlK promoter (Stunnenberg et al., 1988) . The coding region of ICP0 was excised as a BgllI fragment from a cDNA copy of the gene and inserted into the BamHI site of pATA-18. Each clone was inserted into the vaccinia virus genome at the TK locus. TK-virus was selected by plaque purification in TK-143B cells in the presence of bromodeoxyuridine. Precise details of the construction and properties of these viruses will be described elsewhere (X. Zhu, H. G. Stunnenberg, J. Papavassiliou & S. J. Silverstein, unpublished results).
Cell lines. Strain L929 cells (H-2k), EMT6 cells (H-2d
; kindly provided by Dr Ed Cantin, City of Hope National Medical Center, Duarte, Ca., U.S.A.) and simian virus 40-transformed cells C57SV40 (H-2b; kindly supplied by Dr B. Knowles, Wistar Institute, Philadelphia, Pa., U.S.A.) were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco) supplemented with 10~ heat-inactivated foetal calf serum (Gibco) and non-essential amino acids (Gibco). The mouse TK-(Ltk-) cell line, LT-A-, was obtained from Judith Tevethia, Pennsylvania State University, Hershey, Pa., U.S.A. and has been described previously (Wigler et al., 1979) .
Construction of the L3464-A cell line was as follows. Plasmid pRB3464, obtained from B. Roizman, University of Chicago, contains an intact functional HSV-1 ICP4 gene and a neomycin resistance gene linked to the promoter of the HSV-1 TK gene (Arsenakis et al., 1986) . LT-A-cells were transfected with pRB3464 and LT-A-carrier DNA essentially as described (Southern & Berg, 1982) . Briefly, 1-5 x 105 cells were transfected with 0.5 pg pRB3464 DNA and 7-0 gg LT A carrier DNA by calcium phosphate precipitation. The medium was changed at 24 and 48 h post-transfection, with 400 gg/ml G418 (Geneticin, Gibco) added to the culture medium at 48 h post-transfection. Approximately 14 days post-transfection, 11 G418-resistant colonies appeared. Of these clones, one (L3464-l) was passaged further in medium containing 200 p.g/ml G418. These cells were maintained in selective medium throughout the cloning process and during every fifth to eight passage.
Mice. Female C3H/HeN HsdBR (H-2 k) and BALB/c AnNHsdBR (H-2 d) mice were obtained aged 4 to 6 weeks from Harley Sprague Dawley. All other mice, C57BL/10J (H-2b), B10.D2/n SnJ (H-2O), BI0.BR/SgSnJ (H-2 k) and B10.A SgSnJ (H-2") were obtained from Jackson Laboratories.
SD~PAGE and immunoblotting.
Details of the methods used for SDS PAGE have been previously described (Laemmli, 1970; Powell& Courtney, 1974) . The proteins resolved by SDS PAGE were transferred to nitrocellulose and immunoblotting was performed as follows. In Fig. 1 (a, b) the nitrocellulose paper was reacted with monoclonal antibodies specific for ICP4 or ICP0, respectively, (generously supplied by Dr Lenore Pereira, University of California, San Francisco Ca., U.S.A.) for 2 h at room temperature. Bound antibodies were detected on the washed nitrocellulose by incubation with goat antimouse IgG conjugated to alkaline phosphatase, washed and developed with 0-01~ (w/v) nitroblue tetrazolium and indolyl phosphate dissolved in Tris buffer (100 mM-Tris pH 9.5, 100 mM-NaC1, 5 mMMgClz). In Fig 2 the nitrocellulose paper was reacted with rabbit antiserum prepared to purified ICP4 (VP175) polypeptide and bound antibodies were detected by autoradiography as described previously (Courtney & Benyesh-Melnick, 1974) .
Antibodies. Rat anti-CD4 (GK1.5) and rat anti-CD8 (53-6.72) were used as ascites fluids from BALB/c ByJ nude mice inoculated with 5 x 106 of each hybridoma clone. For in vitro depletions, the optimum dilution of each antiserum was determined in a chequerboard titration in Terasaki plates using C3H/Hen thymocytes. Precise concentrations of rat immunoglobulin in each ascites preparation were determined with trapping ELISA. Based upon these values, in vitro blocking experiments for CTL assays used each antiserum at a final concentration of 83 gg/ml in the tissue culture medium. Rabbit LowTox complement was purchased from Cedarlane Laboratories (Accurate Chemical and Scientific).
The production of rabbit antisera to purified ICP4 has been described previously (Courtney & Benyesh-Melnick, 1974) .
Delayed type hypersensitivity (D TH).
Groups of C3H-HeN mice were infected in the left pinna with 107 p.f.u, of vaccinia virus, 5 x 105 TCIDso of HSV-1 or 5 x 106 L cell constructs. Animals were boosted in the opposite ear flaps 2 weeks later and, in experiment 2, reboosted at a further 2 week interval into each rear footpad. After a further 21 days, mice were challenged by injection of 20 gl containing 2.5 x 106 TCIDso (before inactivation) of u.v.-irradiated HSV-1 KOS into the left rear footpad. As a control, the right rear footpad received 20 gl of u.v.-irradiated mock-infected cell extract. As described previously (Schrier et al., 1983) , the protocol of footpad challenging mice originally immunized with an infected Vero cell extract with an HSV-l-infected Hep2 extract (or vice versa) minimized the response to cellular antigens. Footpad swellings were measured 24 h after challenge with spring-loaded calipers. Data are reported as mean differences in footpad swelling between the virus-challenged site and the control site (mm × 102).
Cytotoxicity assays. Virus immune splenocytes were obtained from mice injected in each rear footpad with 0.02 ml of inoculum containing 5 x 106 TCIDso HSV-1, l0 T p.f.u, vaccinia viruses or 5 × 106 L cell constructs 2 to 4 weeks before use. To generate memory CTL populations, splenocytes were cultured in the presence of u.v.-irradiated HSV-1 for 5 days as described previously (Lawman et al., 1980) . Restimulation with H SV-l-infected L cells was performed with mitomycin C-inhibited L cells (8 h post-infection) as described by Jennings et al. (1984) . Immune lymph node cells for the acute CTL populations were obtained by draining the popliteal and retropharyngeal lymph nodes of mice inoculated 5 days previously in the rear footpads and ear flaps with l06 TCIDso of HSV-1 KOS. Cells were then cultured in vitro in the absence of exogenous antigen for 3 days as described previously (Pfizenmaier, 1977) . On the final day of culture, CTL activity was determined using sodium [51Cr]chromate-labelled (200 pCi) mock-or virus-infected target cells in a 4 h assay, as previously described (Lawman et al., 1980) . The released slCr was measured and the percentage specific lysis calculated using the following equation: [(experimental release -spontaneous release)/ (total release -spontaneous release)] × 100.
Measurements for each determinant were performed in at least triplicate and the standard error of the mean was less than 7% The spontaneous release of the targets ranged from 10 to 30~ of the total release.
Limiting dilution analysis (LDA).
Individual microcultures of lymph node cells (5 days post-immunization) were established in Ubottomed wells of plates using 60 replicates for each responder lymphocyte density. Each well contained a predetermined number of responder lymphocytes and 5 × 10 s X-irradiated (1500 R) syngeneic spleen cells. The total well volume was 0-2 ml of NCTC 109 and DMEM (1:1 v/v; Gibco) supplemented with 10% heat-inactivated foetal calf serum, 10 mM-L-glutamine (Gibco), 1% (v/v) non-essential amino acids (Gibco), 10 mM-sodium pyruvate (Gibco), 1 mMoxaloacetic acid (Sigma), 0-2 units/ml bovine insulin (Sigma), 5 x 10 -5 M-2-mercaptoethanol (Sigma), 2 international units of recombinant human interleukin 2 (kind gift from Cetus Corporation) and 2% (v/v) concanavalin A-derived rat T cell growth factor (with 25 mM-~-methylmannoside) prepared as described previously (Von Boehmer et al., 1979) . Cytotoxicity in each well was assessed by the addition of various slCr-labelled target cells to each replicate for 4 h, and determined as described previously (Rouse et al., 1983) .
Lymphoproliferation. Immune splenocytes were obtained from mice 14 to 28 days after immunization in each rear footpad. Cells were then cultured in bulk cultures as described for the induction of memory HSV-l-specific CTL populations by Lawman et al. (1980) . After this initial 5 day culture, the lymphocytes were harvested and washed by centrifugation and then divided into samples at various viable cell densities into U-bottomed wells of microtitre plates (replicates of eight or 12). Total well volume was 0.1 ml and contained 1.0 I~Ci of[3H] -thymidine (ICN Pharmaceuticals). After a further 18 h incubation at 37 °C, the label incorporated into cellular DNA was determined by liquid scintillation and used as a measure of lymphocyte proliferation.
Infectivity assays. Mice were immunized as in the cytoxicity assays.
These animals were then boosted twice more at 14 day intervals. Two weeks after the last infection, animals were challenged with 5 × 104 TCID5o HSV-1 into the left ear flap. The ear flaps were removed 3 days later, homogenized and the residual infectious virus titre was determined in a microtitration assay on Vero cell monolayers .
Lethality experiments. Animals received their primary immunization as described for the infectivity assays and were then boosted 1 week later with the same dose administered intraperitoneally (i.p.), The 9-week-old animals were lethally challenged 1 week later with an i,p. inoculum of 5 x l0 s p.flu, of HSV-1, McCrae strain. Animals were monitored daily for clinical signs over a period of 21 days. Results are expressed as the number which had died by this day, or percentage mortality. No more animals died after this time.
Statistical analysis. Calculation of CTL precursor frequencies by limiting dilution analysis was performed as described by Taswell (1981) . This analysis yielded the frequencies, their 95~ confidence limits and their probability of single hit kinetics. All other analyses were performed using Student's t-test.
Results
Expression of ICPO and ICP4 in murine cell lines
The protein products synthesized in Ltk-cells infected with the recombinants, wild-type HSV and vaccinia viruses were examined by Western blotting (immunoblot) with monoclonal antibodies specific for ICP0 or ICP4. ICP0 produced in HSV-l-infected cells has an apparent Mr of 110K, as determined from its electrophoretic mobility in SDS-PAGE, and is located in the nucleus (Ackermann et al., 1984; Wilcox et al., 1980) . A predominant species of ICP0, with an electrophoretic mobility indistinguishable from that of ICP0 synthesized in cells infected with HSV-1, was detected in whole cells (Fig. 1 b) or nuclear extracts (data not shown) from cells infected with Va0. A less abundant, more rapidly migrating species, which is presumably a degradation product of the bona fide protein, is also detected in extracts prepared from cells infected with Va0 for 20 h. ICP4 can exist in several different phosphorylated states in infected cells; however, the bulk of the protein migrates with an apparent Mr of 175K (Courtney & Benyesh-Melnick, 1974; Pereira et al., 1977; Wilcox et al., 1980) . Under the conditions of electrophoresis used in this assay we detected two bands of ICP4 in extracts from cells infected with HSV-1, and immunoreactive bands that migrated with a similar mobility in cells infected with V~4 (Fig. 1 a) . Prolonged development reveals the presence of ICP4 at 6 h after infection with Va4. The levels of protein synthesized by the V~4 recombinant were similar to those which accumulate in cells infected with HSV, whereas the level of ICP0 that accumulated in cells infected with Ve0 was slightly less. The level of ICP4 in L3464-1 cells was also determined, relative to the expression of ICP4 in equivalent numbers of HSV-1-or Vc~4-infected Ltk-cells, by immunoblot analysis with rabbit antisera specific for ICP4 (VP175). The immunoautoradiograph in 
Recognition of lCP4 by HSV-l-specific CTL
Various murine cell lines were infected with the Va4 and Va0 vaccinia virus to determine whether they were recognized by HSV-l-specific CTL from mice of differing H-2 genotypes. The data in Table 1 show that ICP4 was the only HSV-1 gene product recognized and then only by CTL populations obtained from C3H or B10.BR (H-2 k) mice. In addition, L cells (H-2 k) transfected with the ICP4 gene were also subject to lysis. Even though the transfected cells expressed less ICP4 than did V~4-infected cells, levels of lysis were approximately equivalent. Phenotype analysis by the negative selection approach demonstrated that the effector lymphocytes were CD8 ÷ and CD4-( Table 2 ). The results of experiments using effectors from a variety of mouse strains to establish the restriction profile indicate that the H-2D k allele was the major restricting element (Table 1 ) since C T L from H -2 K k, D d failed to recognize V~4. Thus the ICP4-specific C T L were classical CD8 + M H C class I-restricted lymphocytes.
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Analysis of lCP4-specific CTL by limfling dilution
Effector cells from C3H mice were cultured u n d e r limiting dilution conditions to allow an estimate of the frequency of HSV-l-specific C T L which recognized ICP4. The experiments reported in Table 3 show that an average of 2 7~ (range 21 to 6 8~) of the p r i m a r y H-2 krestricted C T L response was specific for ICP4. U n d e r these conditions, specific lysis of histocompatible cells infected with V~0 was not detected. Split well analysis of L D A -d e r i v e d ICP4-reactive cultures revealed that they were also specific for H S V -l -i n f e c t e d histocompatible cells, but failed to lyse V T K --i n f e c t e d cells. I n addition, their specific lyric capability was i n h i b i t e d by high concentrations of a n t i -C D 8 antibodies (data not shown).
Induction of an HSV-l-specific immune response following immunization with V~O or V~4
Several different strains of mice were i m m u n i z e d a n d boosted with either V~0 or V~4 and then evaluated for their ability to control a subsequent infection with HSV-1. The two approaches used were protection against a lethal i.p. infection and rapid clearance of virus * After treatment with anti-CD4 or anti-CD8, acute CTL populations were incubated for 1 h with complement (C') at 37 °C and assessed for lyric capability in a 4 h chromium release assay. Effector/target ratio, 50 : 1.
Results are means of triplicate cultures. Significant results are underlined. * Cells labelled and infected 4 to 6 h prior to use in a 4 h chromium release assay.
t Data generated in the same experiment.
following epithelial infection of the ear pinna. We consider the latter approach to be a more stringent test of immunity. However, by neither of the two criteria did ICP4 or ICP0 confer protection against HSV-1 (Table 4) . However, this was not associated with their failure to induce an HSV-l-specific immune response as HSVspecific DTH (Table 5 ) and lymphoproliferative responses (data not shown) were demonstrated in both V~0-and V~4-immunized mice. Unexpectedly, V~4 immunization failed to sensitize C3H mice for a subsequent HSV-specific memory CTL response. Accordingly, whereas 5 days of in vitro stimulation with HSV-1 antigen induced lymphoproliferation, levels of CTL activity were insignificant (Table 6 ). Even the stimulation of spleen cells from Vc~4-immunized mice with HSV-l-infected L cells failed to demonstrate HSV-1-specific CTL conclusively (Table 6 ).
As a measure of antibody responses to immunization with Vc~4 and V~0, Western blot analysis and neutralization were used. Neutralizing antibodies were not detected and, even after two exposures to the immunogens, levels of antibody were barely detectable by Western blotting (titres not exceeding 1/10, data not shown).
In summary, immunization with either V~0 or V0c4 failed to induce any significant protection against HSV-1 despite the detection of lymphoproliferation and DTH responses to the immediate early gene products.
Discussion
Immediate early (IE) gene products of HSV-1 have been previously shown to provide target antigens for MHC class I-restricted CTL, but which of the five gene products contributed to the target antigens has to our knowledge not been addressed (Martin et al., 1988) . In the present report, several gene expression systems were used to evaluate recognition of two IE , 20, 23, 13, 2, 8, 6, NO* 6+2 VgBll 16, 18, 19, 17, 20 18 ± 1 V~0 20, 12, 15, 17, 11 15+3 Vc~4 15, 12, 21, 14, 17, 16, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] 1, 4, 0, 5, 17, 22, 7, 21 18 ± 6 * ND, Not done.
proteins, ICP0 and ICP4. Our results, using effector cells from three strains of mice (H-2 k, H-2 d and H-2b), only show recognition of ICP4 and then only by H-2 k CTL. Using recombinant inbred strains, ICP4, CD8 ÷ and CD4-specific CTL appeared to be restricted to the H-2D k allele, although further analysis with other H-2 recombinant target cells will be necessary to confirm this. We and others have also shown IE protein-specific CTL in both H-2 d (Martin et al., 1988) and H-2 b (S.
Jennings, personal communication) mice but neither ICP0 nor ICP4 appeared to be recognized by these strains. Presumably one or more of the remaining three IE gene products (ICP22, ICP27 and ICP47) provide target antigens in these instances. This topic is currently Rouse, unpublished results) . It is possible that the lack of recognition by some strains of mice could be due to poor expression of the recombinant gene products in certain target cells. In other well studied systems it has been difficult to relate detectable protein levels to susceptibility to CTL. Indeed, lysis may be evident in the absence of significantly detectable protein expression (Townsend et al., 1985) . With the exception of the H-2 k strain, we lacked alternative expression systems to determine whether the use of vaccinia virus as the vector was responsible for defective presentation of the ICP antigens as has been suggested in other viral systems (Townsend et al., 1988) . However, all of the targets could be lysed by vaccinia virus-specific CTL (data not shown), thereby excluding the possibility that the vaccinia virus recombinants were interfering with the levels of class I MHC antigen expression or the antigen processing mechanism.
To confirm the specificity of the ICP4-reactive CTL as well as to estimate CTL precursor frequencies, LDA was used. Under conditions ensuring a high proportion of monoclonal cells, HSV-specific CTL lysed both ICP4-transfected and V~4-infected MHC-compatible targets. Approximately one-third of the HSV-1-specific CTL was ICP4-specific. As this frequency estimate approximated that for the total IE-specific CTL population, it could mean that, in H-2 k mice, all IE reactivity is ICP4-specific. Unlabelled target competition was used to confirm this notion. Our results (not shown), however, were variable and usually showed incomplete lysis inhibition of IE targets (generated by cycloheximide reversal) by ICP4-expressing target cells. This could mean either that antigens other than ICP4 are also involved as targets or that there is a quantitative or technical explanation. Accordingly, the levels of expression of ICP4 or CTL-recognized fragments in these target cells could be inadequate to act as effective inhibitors. Clearly, as measured serologically, both V~4-infected (at 6 h post-infection) and ICP4 L cell transfectants expressed less ICP4 than is found in HSV-infected cells subjected to cycloheximide reversal (Martin et al., 1988 and data not shown) .
It is curious that for many viruses investigated only a few proteins appear to provide CTL recognizable epitopes. Often, non-structural proteins synthesized early in the replication cycle act as targets which, in several instances, may dominate the response (Reddehase & Koszinowski, 1984; Borysiewicz et al., t988; Sugden, 1989) . This is true for certain herpesviruses, although not for HSV (Martin & Rouse, 1989) . Conceptually, there could be advantages to the host in recognizing early gene products. Accordingly, since class I MHC proteins have only a single antigen-binding site (Bjorkman et al., 1987; Maryanski et al., 1988) , an important aspect of recognition is for an epitope to compete with other epitopes capable of binding to the same MHC protein. The first and most abundant proteins in a herpesvirus infection are IE proteins and processed material from those could saturate available MHC-binding sites. As an added bonus to host defence, CTL specific for IE proteins may kill such cells before new infectious virus has been assembled.
The immunological significance of early protein recognition has been intensively studied in CMV infections of BALB/c mice, where an IE viral protein, pp89, accounts for the bulk of the CTL response (reviewed in Koszinowski et al., 1987) . Immune responses against pp89 alone provide potent protection against infection, an effect mediated principally by MHC class I CD8 + T cells (Jonjic et al., 1988) . In our studies, despite the fact that around 30 ~ of HSV-specific CTL were ICP4-specific, neither immunization with ICP4-transfected cells or Vet4 could induce HSV-specific CTL. This discordance between target cell recognition by CTL in vitro and their in vivo induction has also been noted in the lymphocytic choriomeningitis virus system when using recombinant vaccinia virus constructs as immunogens (Whitton et al., 1988) . Possibly the failure to induce CTL in vivo has a quantitative explanation, with inadequate synthesis and processing of CTLgenerating antigens or a failure to elicit other regulatory cells and factors required for CTL induction. We are further investigating this issue by supplying various lymphokines assumed to be generated by regulatory cells.
Although immunization with recombinant vaccinia virus containing an IE gene induced protection in the murine CMV system, neither V0~0 nor V~4 was immunoprotective in the three strains of mice studied. None of the mice generated CTL responses, but evidence for T cell immune induction was obtained both by measurements of lymphoproliferation and DTH. Possibly the failure to elicit local protection against even a low challenge dose of virus was associated with the barely detectable antibody response. Thus, we suspect that unless antibody is present at the time of local challenge, virus will multiply rapidly at the site. Later, infected cells will be cleared by T cells but these take many hours or days to be recruited to the site and to be differentiated into effector cells. In consequence, for a vaccine to be effective against HSV, it should be capable of inducing both humoral and T effector cell responses. We are currently testing these hypotheses using multiple vectors that express several HSV gene products and are capable of inducing different aspects of the immune response to HSV.
